Principal Investigator
Scott Elman
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230165
Clinical Trial Summary
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PF-06823859 in Participants with Active Idiopathic Inflammatory Myopathies (including participants with Active Dermatomyositis or Polymyositis)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other